Objectives: Geographic tongue or migratory glossitis is an inflammatory disorder with unknown etiology. Considering the accompanied burning pain, taste dysfunction, and lack of definite cure, it is important to treat this condition symptomatically. The objective of the current study was to compare the efficacy of a combination of 0.05% retinoic acid and 0.1% triamcinolone acetonide with that of triamcinolone acetonide alone for treatment of symptomatic geographic tongue.
INTRODUCTION
Geographic tongue or benign migratory glossitis is defined as an inflammatory disorder with unknown etiology, characterized with a decrease in the number of papillae in the dorsum and lateral border of the tongue circumfusing with the formation of red, round patches with white distinct borders that give the tongue a map-like appearance. Changes in lesions almost occur on a daily basis. Its prevalence has been reported to be 2-3%. It seems that its distribution is equal in both males and females. Remission and relapse are also seen over time [1] . Although the main etiology of geographic tongue remains unknown, some factors including emotional stress, vitamin deficiency, allergy, genetic factors, immune disorders, bacterial or fungal infection and systemic diseases are known to play a causative role. The lesions need to be treated in case of presence of pain, burning sensation, taste diminution, cancer phobia or aesthetic concerns [2] . There is not a definite cure for this condition. Topical steroids, retinoic acid, cyclosporine, antihistamine, tacrolimus and immune system regulators have been used in proposed treatment plans, yet they are neither specific nor curative. They actually modulate inflammatory and immunological responses, which is their chief mechanism of action [3] . In a study by Abe et al, [4] a 54 year-old woman with painful geographic tongue failed to respond to therapy with 20mg of oral prednisolone and topical dexamethasone ointment on a daily basis. She was subsequently suspected for psoriasis, for which she received cyclosporine with favorable outcome [4] . Tacrolimus, a macrolide immunesuppressant with anti-inflammatory effects similar to cyclosporine with a mechanism of action of 1L2 inhibition, was proven successful in treating two patients with geographic tongue, who failed to respond to non-steroidal antiinflammatory drugs and vitamin B12 [5] . Anita et al, [6] pointed to a number of symptomatic treatment options in their study in 2011, including oral hygiene maintenance, hydration, acetaminophen, local anesthetic mouthwash solution, anti-histamines, anxiolytics, corticosteroids, retinoic acids and cyclosporine. Helfman [7] supported retinoic acid solution and its efficacy for treating three cases of geographic tongue. Sigal and Mock [8] reported successful symptomatic treatment with local as well as systemic anti-histamines. Vahedi et al, [2] showed beneficial effects of topical zinc sulfate ointment for treatment of geographic tongue. There is still no definitive cure for geographic tongue. Corticosteroids are considered effective among the available options. Triamcinolone acetonide is preferred over other corticosteroids since it contains sodium along with features similar to those of other corticosteroids [9, 10] . Retinoic acid can stimulate immune response including macrophages' activity and cellular immune mechanisms [11] . Since both retinoic acid and topical corticosteroids have therapeutic and ameliorating effects on geographic tongue, the combination of the two may probably have a greater impact. We intended to assess the efficacy of the combination of the two on geographic tongue. This can be a step forward towards the inclusion of this compound in the National Generic Pharma List, for a breakthrough in providing health and minimizing harm in affected patients.
MATERIALS AND METHODS
This randomized controlled double blind clinical trial was conducted on 28 patients referred to Oral Disease Department of the Faculty of Dentistry, the International Campus of Tehran University of Medical Sciences and Razi Dermatology Hospital. Twenty eight patients with symptomatic geographic tongue (confirmed by an oral disease specialist) who met the inclusion criteria and signed written informed consent form were included in this study. This study was approved by the Ethics Committee of Tehran University of Medical Sciences (130/2356/91) and registered in www.irct.ir (#201211062464n6). The patients were selected using the block randomization method and were divided into two groups of A and B with 14 patients in each group. The inclusion criteria were patients above 18 years old with symptomatic geographic tongue. Patients with a history of systemic or topical corticosteroid use for at least one month before treatment, smokers, pregnant women, those with any serious systemic disease that may interfere with the drugs such as diabetes mellitus, hypertension, heart disease, neurological problems, hepatitis, renal disease, chemotherapy and radiotherapy were excluded. The lesion was photographed before drug administration. Then, one modality was randomly prescribed for the participants. Patients were requested to apply 0.1% topical triamcinolone acetonide in an oral base or a combination of 0.05% retinoic acid and 0.1% triamcinolone acetonide in an oral base on their lesions. Patients were also instructed to wash their mouth before the application of drugs and avoid eating Proper amounts of the afore-mentioned active substances were mixed and placed in tubes, labeled and kept at room temperature. Symptoms (pain and burning sensation) were assessed and recorded using the visual analog scale in a range of 0-100 [6] . Follow-up for detection of possible recurrence was done for two months after cessation of treatment (at the end of each month). The satisfactory outcomes were positive response to treatment and lesion's resolution with regard to size, level of pain and burning sensation. The healing process was The resolution of pain and burning sensation was defined as reduction in their severity. Following complete response to treatment, the patients were followed up for two months for possible recurrence. The SPSS version 11 software was applied to compare the two therapeutic modalities. Qualitative variables were reported as relative frequency (in percentage) while quantitative variables were reported as mean and standard deviation. Fisher's exact test was used to compare the responses to treatment between the two groups and in order to compare the response time between the groups the KaplanMeier curve and log-rank test were used. Level of significance was set at P<0.05.
RESULTS

The study participants were 28 patients referred to Department of Oral Disease, Faculty of Dentistry, International Campus of Tehran University of Medical Sciences and Razi
Dermatology Hospital including seven (25%) males and 21(75%) females. There were 10 females (10.17%) and four males (4.71%) in the triamcinolone group and 11 females and three males (6.78%) in the combined drug group. With regard to their employment status, there were 11 (39.3%) housewives, 16 (1.57%) employees and one (3.6%) worker. With regard to the duration of the disease, 21 (75%) patients had the disease for less than six months and seven (25%) had the disease for more than six months. In terms of family history for the disease, 21(75%) had positive and seven (25%) had negative family history. The mean age was 40 years. At the beginning of the study, the severity of pain was not significantly different between the two groups (P=0.22). Similarly, after 10 days of drug application, there was no significant difference in the severity of pain between the two groups (P=0.07). One month after cessation, there was no statistically signifi-www.jdt.tums.ac.ir January 2016; Vol.13, No.1
Fig. 2:
Comparison of changes in the lesion's extension cant difference in the severity of pain between the two groups (P=0.98) (Fig.1) . The comparison of pain severity throughout all three stages of the study revealed that pain decreased during the experiment.
At the beginning of the study, the extension of lesions was not significantly different between the groups (P=0.28). Similarly, after 10 days of drug application there was no significant difference in this regard between the two groups (P=0.48). One month after drug discontinuation, there was no statistically significant difference in the lesions' extension between the two groups (Fig. 2) . Although differences in the severity of burning sensation were observed at different stages of the study indicative of a reduction in burning sensation during the experiment, there was no significant difference at different stages between the two groups (Fig. 3) .
DISCUSSION
Geographic tongue, also known as benign migratory glossitis or benign transient plaque, usually starts with a decrease in the number of papillae on the lateral border and tip of the tongue, which are also redder and smoother than those in the other parts. These areas spread peripherally with the formation of red patches and well-circumscribed annuli that are delineated with whitish-yellow borders, giving the tongue a map-like appearance. It is not exclusive to a specific gender or race, and has an unknown etiology. The prevalence has been reported in a range of 1 to 2.5%, occurring in males and females equally [1] . In the current study, in which the efficacy of triamcinolone was compared with that of a combined regimen (triamcinolone acetonide and retinoic acid) in 28 patients with symptomatic geographic tongue, 75% of the participants were women and 25% were men while 75% of the patients had a positive family history for the disease. Difference in the severity of pain was observed in both groups in different stages of the experiment, representing pain reduction and recovery. A comparison between the stages revealed a significant pain reduction between stages one and two and also one and three while no difference was recorded between stages two and three. Lesion size varied throughout the study at different stages, yet there was no statistically significant difference as to this variable between the two groups at the end of the study. Although difference in the severity of burning sensation was observed at different stages of the study (a reduction throughout the specified period), there was no significant difference at the various stages between the two groups. No adverse effects were reported, without any substantial statistical disparity in this respect. The two groups were not different regarding patient satisfaction either (P=0.75). Recurrence of symptoms was not observed in any group. It can be concluded that the efficacy of the combination of retinoic acid and triamcinolone acetonide for symptomatic treatment of geographic tongue was similar to that of triamcinolone acetonide alone. One of the advantages of the current study was the use of a combination of two drugs. Retinoic acid is a synthetic type of vitamin A with antiinflammatory, anti-keratotic and immuneregulatory features. Its anti-inflammatory components can inhibit macrophage and neutrophil infiltration through the blood vessels to the adjacent tissues (chemotaxis), can accelerate the healing process and decrease the risk of malignancy in epithelial cells. Retinoic acid plays a role in prevention of oral cancer and can cause regression of premalignant leukoplakia [1, 11] . The combination of these two drugs can reduce inflammation via two different mechanisms: corticosteroids prevent the initiation of inflammatory cascade by inhibiting the enzyme release while retinoic acids interfere with arachidonic acid cascade, resulting in wound healing, angiogenesis stimulation and an increase in local blood flow [19, 20] . On the other hand, the dose of corticosteroids is lower in drug combinations, and resultantly, their related complications decrease.
CONCLUSION
The combination of triamcinolone and retinoic acid was not shown more effective than triamcinolone alone in treating geographic tongue symptomatically.
